A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

Vimseltinib is now an FDA-approved treatment for patients with tenosynovial giant cell tumor, based on findings from the ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital have announced their newest class of ...

A 6-year-old boy died after he was diagnosed with glioma, a deadly brain tumour that doubled his weight in a short span.

Children’s Minnesota is testing the safety of a new vaccine combination to combat one of the deadliest pediatric cancers, which could give new hope for children who would otherwise typically die ...

As with the Philadelphia Eagles at half time of Super Bowl LIX, a team of ASX biotechs is not quite over the line but has the ...

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

Researchers explore the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during ...